A survey of 1,000 specialists in pharmaceutical anti-counterfeiting measures surveyed have suggested that faking of medicines will become increasingly severe in the coming years, and that drugmakers will invest more in defensive measures.SecuringPharma, in a December 24th post, reports on a survey that was created as a part of the pre-conference research for IQPC's Pharmaceutical Anti-Counterfeiting conference to be held in Amsterdam on February 15th-17th.
According to the SecuringPharma post:
• Almost two third of those polled in the survey (61.5 per cent) expected the threat of counterfeiting to increase in 2011, while more than half (53.8 per cent) said they were planning to increase their budget for investment in anti-counterfeiting area.
• With regard to the anti-counterfeiting technology they were using, just 53 per cent indicated they were satisfied with it and 23 per cent said they were not content with their current protection.
• A vast majority (84 per cent) said that they were looking to invest in new anti-counterfeiting measures, according to Pharma IQ, a division of conference organiser IQPC which carried out the poll.
• Emerging markets in Asia - and especially China - were perceived as the major source of the anti-counterfeit drugs by half of the respondents.
• 21 per cent cited the Internet as the major threat for the pharmaceutical market in the context of counterfeiting, with around the same proportion identifying organised crime as their top concern.
• On a positive note, while the results indicated that the perceived threat of counterfeit medicines was significant, most of those polled (84.6 per cent) said they believed it is possible to win the war with pharmaceutical counterfeiters.
The results of the survey are in line with all of the most recent media reports and statistics that are emerging at the close of 2010. The criminal enterprise of drug counterfeiting is on the rise and the threat to supply chains and populations around the world is very real.
Of comfort is the increased realization and reaction by governments, industry and consumers of this threat. In the past most members of the supply chain were looking for government mandates before moving to protect their inventories. Based on this survey it would appear that they are now in a more proactive mindset.
Ultimately it is incumbent on the supply chain members and the consumer to be vigilant in protecting themselves from this threat.
To read the entire SecuringPharma post, visit: http://www.securingpharma.com/40/articles/815.php
To learn more about the IQPC Pharmaceutical Anti-Counterfeiting Conference, visit: http://www.pharmaceuticalanticounterfeiting.com/Event.aspx?id=405182
To learn more about anti-counterfeiting technologies for pharmaceuticals, visit: http://www.xstreamsystems.net/
Posts
No comments:
Post a Comment